HPLC vs. Mass Spectrometry: Which Is Better for Peptide Testing?

When evaluating research peptide quality, two analytical methods appear most frequently in laboratory reports: HPLC (high-performance liquid chromatography) and mass spectrometry (MS). They are often mentioned together, but they measure fundamentally different things. Understanding the distinction — and the limitations of each — is essential for interpreting any peptide analysis report correctly.

The short answer to "which is better" is: neither alone is sufficient. The complete answer requires understanding what each method actually does.

What HPLC Measures

HPLC is a separation and quantification technique. It separates compounds in a sample based on their chemical properties (primarily hydrophobicity in reversed-phase HPLC) and measures how much of each compound is present relative to the total.

The output — a purity percentage — tells you what proportion of UV-detectable material in the sample is the dominant compound. A result of 97.5% means the main peak accounts for 97.5% of the total UV-detected peak area under the analysis conditions.

What HPLC answers: How pure is the dominant compound in this sample?
What HPLC does not answer: What is that dominant compound?

What Mass Spectrometry Measures

Mass spectrometry measures the mass of molecules. It ionises compounds and measures the mass-to-charge ratio (m/z) of the resulting ions, producing a spectrum that identifies the molecular weight of compounds in the sample.

For peptide analysis, ESI-MS (electrospray ionisation mass spectrometry) is the most common method. It detects the intact molecular weight of the dominant compound, which is then compared to the theoretical molecular weight of the expected peptide.

What MS answers: Is the dominant compound the expected molecule?
What MS does not answer: What percentage of the sample is that compound?

Why Both Methods Together Answer the Full Question

The combination of HPLC and MS addresses a question that neither method can answer alone:

"Is this sample predominantly the expected compound, and how pure is it?"

• HPLC alone: "The sample is 97% pure" — but 97% of what?
• MS alone: "The dominant compound has the correct molecular weight" — but how much of the sample is that compound?
• HPLC + MS: "The sample is 97% the correct compound, confirmed by both purity quantification and molecular weight."

A CoA containing only HPLC data is incomplete. A CoA containing only MS data is equally incomplete. The two methods are complementary, not interchangeable.

Where Each Method Falls Short Alone

HPLC Limitations

• Cannot identify what the peaks are — only that they are present and how large they are
• Cannot distinguish between structural isomers or analogues with identical retention times
• Cannot detect compounds that do not absorb UV at the detection wavelength
• A 99% purity result on HPLC is meaningless as quality evidence without MS identity confirmation

Mass Spectrometry Limitations

• Does not quantify the proportion of a compound in the sample — presence is confirmed, not amount
• Cannot distinguish between compounds of identical mass (isobaric compounds)
• Some ionisation techniques fragment large molecules, making interpretation more complex
• Requires calibration and interpretation by a qualified analyst

When Additional Methods Are Needed

For specific quality concerns beyond purity and identity, additional methods are required:

• Endotoxin testing (LAL assay) — neither HPLC nor MS can detect bacterial endotoxins; dedicated testing is required
• Amino acid analysis — confirms the composition and stoichiometry of the amino acid sequence
• Elemental analysis — confirms the empirical formula and can detect certain inorganic contaminants
• Microbiological testing — required to assess sterility, separate from chemical analysis

At Peptest, standard analysis includes both HPLC purity and MS identity. Endotoxin testing, pathogen screening, and microbiological testing are available as additional analyses. The standard pair — HPLC + MS — is the minimum that provides a meaningful quality assessment for a research peptide sample.